Genome-wide Association Study of Development of Collateral Circulation for Patients With Coronary or Peripheral Artery Disease
NCT ID: NCT05043948
Last Updated: 2021-09-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
400 participants
OBSERVATIONAL
2015-08-21
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetics of Peripheral Artery Genomics
NCT00615121
Inflammation Genomics and Atherosclerosis - Ancillary to CARDIA
NCT00046605
Modeling DNA Diversity in Cardiovascular Health/Disease
NCT00005490
Inflammatory Genomics in Human Carotid Artery Disease
NCT00070668
Molecular and Morphologic Characterization of Circulating Endothelial Cells
NCT01005485
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Coronary Artery Disease_collateral flow grade 2
Blood samples
for evaluation of the genome-wide association study
Coronary Artery Disease_collateral flow grade 0
Blood samples
for evaluation of the genome-wide association study
Peripheral Artery Disease_collateral flow grade 2
Blood samples
for evaluation of the genome-wide association study
Peripheral Artery Disease_collateral flow grade 0
Blood samples
for evaluation of the genome-wide association study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood samples
for evaluation of the genome-wide association study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic total occlusive lesion from the coronary or peripheral angiogram
Exclusion Criteria
* Hepatic dysfunction
* Thrombocythemia or thrombocythemia
* Planned major surgery in 1 year
* History of gastrointestinal haemorrhage
* Malignant tumor
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jung-min Ahn
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jung-min Ahn
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asan Medical Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GWAS_collateral
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.